We are live on ! Find out more
AI

Arena Investors Portfolio holdings

AUM $12.5M
1-Year Est. Return 0.27%
This Fund
S&P 500
This Quarter Est. Return
-1.09%
1 Year Est. Return
-0.27%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.5M
AUM Growth
+$5.86M
Cap. Flow
+$71M
Cap. Flow %
567.07%
Top 10 Hldgs %
98.58%
Holding
37
New
15
Increased
Reduced
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 8.55%
2 Industrials 4.32%
3 Healthcare 2.11%
4 Communication Services 0%

Similar funds

Arena Investors's Q2 2024 Portfolio in Review

As of Q2 2024, Arena Investors held 37 positions worth $12.5M, up 88% from $6.67M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Arena Investors deployed $71M of net new capital in Q2 2024, opening 15 new positions. Its largest new stake was Invesco QQQ Trust: 162,415 shares worth $21.2K.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, followed by Industrials and Healthcare.

On the sell side, the most notable exit was Aspire Biopharma, an estimated $1.66M sold.

  • Arena Investors's largest Q2 2024 buy was Invesco QQQ Trust: 162,415 shares worth $21.2K.
  • Arena Investors fully exited Aspire Biopharma in Q2 2024, selling an estimated $1.66M.
  • Arena Investors's ten largest holdings make up 99% of its $12.5M portfolio in Q2 2024.
  • Arena Investors opened 15 new positions and closed 11 in Q2 2024.
  • Arena Investors's portfolio value rose 88% quarter-over-quarter to $12.5M.

Based on Arena Investors's 13F filing for Q2 2024, filed 14 Aug 2024.